Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.23.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Cash flows from operating activities:    
Net loss $ (21,955) $ (4,974)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization of property, plant and equipment 1,428 1,253
Amortization of intangible assets 153
Share-based compensation charges 945 895
Share-based 401(k) employer match expense 396 358
Foreign exchange (gain) loss (707) 773
Unrealized loss on marketable securities 553
Changes in operating assets and liabilities:    
Accounts receivable 653 (5,127)
Inventories (310) (1,211)
Prepaid expenses and other assets 1,080 743
Accounts payable – trade 4,678 (1,272)
Accrued liabilities, other current liabilities and other liabilities (1,099) 1,183
Total adjustments 7,064 (1,699)
Net cash used in operating activities (14,891) (6,673)
Cash flows from investing activities:    
Purchases of marketable securities (55)
Capital expenditures (1,521) (2,247)
Net cash used in investing activities (1,521) (2,302)
Cash flows from financing activities:    
Repayments under mortgage agreement and finance leases (157) (114)
Net cash used in financing activities (157) (114)
Effect of exchange rate changes on cash and cash equivalents 20 (26)
Decrease in cash and cash equivalents and restricted cash (16,549) (9,115)
Cash and cash equivalents and restricted cash - beginning of period 22,603 14,274
Total cash and cash equivalents and restricted cash - end of period 6,054 5,159
The composition of total cash and cash equivalents and restricted cash is as follows:    
Cash and cash equivalents 5,054 4,159
Restricted cash included in other assets 1,000 1,000
Total cash and cash equivalents and restricted cash $ 6,054 $ 5,159